course details
Bridging the Gap: Continuing Education in Cell and Gene Therapies
Calendar for courses in 2027 now available
LUMC
Avans
PharmaNL
A flexible programme of specialised courses covering the CGT value chain. Follow individual modules or combine multiple courses based on your learning needs.
Bridging the Gap offers flexible, modular continuing education in cell and gene therapies (CGT), combining up-to-date scientific knowledge with practical, interdisciplinary training. Led by LUMC in collaboration with Avans University of Applied Sciences and HU University of Applied Sciences Utrecht, the programme helps life sciences professionals build the skills needed across the CGT value chain.
Bridging the Gap offers flexible, modular continuing education in cell and gene therapies (CGT), combining up-to-date scientific knowledge with practical, interdisciplinary training. Led by LUMC in collaboration with Avans University of Applied Sciences and HU University of Applied Sciences Utrecht, the programme helps life sciences professionals build the skills needed across the CGT value chain.
Language
English
Entry level
See specific course
Accreditation
Certificate of participation
7 modular courses
Bridging the Gap 2027
7 modular courses across the CGT value chain
Courses throughout 2027
Leiden, Breda, Utrecht & online
Dates and prices vary per course
View courses in this programme
From foundations to specialised techniques
Explore how Bridging the Gap connects fundamental knowledge with practical expertise across the CGT value chain.
- Fundamental
technologies - Screens &
methods - Assays &
protocols - CMC
principles - Clinical
development - Translation
into practice
Module 1
Foundations of the CGT field
Module 2
In-depth techniques
Mechanism of action
- Stem cell & organoid culture
- CRISPR / Cas technology & delivery
Validation, safety & efficacy
- Serum-free culture
- Flow cytometry
CMC & QC focus
- Mass photometry: QC for AAVs and lentiviral production
- Endotoxin and mycoplasma analysis
Format: short, modular, practice-linked
Course calendar 2027
Explore our upcoming training courses in cell and gene therapies. The programme includes an introductory course covering the ATMP value chain and specialised courses focusing on technologies, manufacturing and quality control.
| Course | Lead | Format | Planned live dates |
|---|---|---|---|
| Introduction to the ATMP value chain | LUMC | Self-study + 3 live half-days | 17–19 February 2027 |
| Stem cell and organoid cultures | HU | Self-study + 2 live days | 29 March – 2 April 2027 |
| Mass photometry: QC for AAVs and lentiviral production | Avans | Self-study + 2 live days | 13–14 May 2027 |
| Receptor presentation using flow cytometry | Avans | Self-study + 2 live days | 10–11 June 2027 |
| Endotoxin and mycoplasma analysis | Avans | Self-study + 2 live days | 24–25 June 2027 |
| CRISPR/Cas technology for cell and gene therapy | LUMC | Self-study + 2 live days | Autumn 2027 |
| Serum-free cultivation techniques for CGT | HU | Self-study + 2 live days | Autumn 2027 |
All dates are planned and may change. Course titles link to further information where a course page is available.
Target audience
Life-science professionals with an HBO or academic background, including researchers, laboratory specialists, biotech/pharma employees, clinicians and healthcare analysts; modules may also be reused by lecturers/researchers.
Education level
Postgraduate education, Professional/continuing education
Learning outcomes
Understand the cell and gene therapy (CGT) value chain, from scientific discovery and therapeutic development to manufacturing, clinical application and patient access.
Explain key scientific principles and technologies underlying cell and gene therapies, including gene editing, stem cell technologies and advanced therapeutic medicinal products (ATMPs).
Develop specialised technical knowledge and practical skills in selected areas of CGT development, laboratory techniques and quality control.
Recognise regulatory, ethical, clinical and economic considerations that influence the development and implementation of advanced therapies.
Apply acquired knowledge to professional practice, connecting scientific and technical concepts with real-world challenges in research, healthcare and industry.
Strengthen interdisciplinary understanding by recognising the roles and perspectives of different professionals involved in developing and delivering cell and gene therapies.
Topics
Cell therapy
Gene therapy
Translational medicine
Drug discovery & development
Regulatory affairs
Manufacturing & bioprocessing
GMP
Quality assurance (QA)
Clinical development
Ethics
Health economics & market access
Valorisation & entrepreneurship
Learning experience
In-person
Lecture
Workshop
Hands-on laboratory
Case-based learning
Team/group work
Workshop
Hands-on laboratory
Case-based learning
Team/group work
Online
Self-paced learning
Recorded lecture
Case-based learning
Recorded lecture
Case-based learning
Schedule
In-person
See specific course
Online
See specific course
Full programme
Want to know more? Explore the complete programme details, background, course calendar and organiser information in the document below.
Meet the course organizers
Niels Geijsen
Professor of Developmental Biology and Regenerative Medicine and Head
Leiden University Medical Center
Raymond Pieters
Professor of Applied Sciences, Innovative Testing in Life Sciences & Chemistry
HU University of Applied Sciences Utrecht
Clara Martínez Mir
Founding Coordinator for Education in Regenerative Medicine
Leiden University Medical Center
7 modular courses
Bridging the Gap 2027
7 modular courses across the CGT value chain
Courses throughout 2027
Leiden, Breda, Utrecht & online
Dates and prices vary per course
View courses in this programme
